Literature DB >> 12689833

Determination of a glucose-dependent futile recycling rate constant from an intraperitoneal glucose tolerance test.

Jun Xu1, W N Paul Lee, Gary Xiao, Chuck Trujillo, Vicky Chang, Lilia Blanco, Felicia Hernandez, Beau Chung, Sahar Makabi, Sayed Ahmed, Sara Bassilian, Mohammed Saad, Irwin J Kurland.   

Abstract

Increased glucose cycling between glucose and glucose-6-phosphate is characteristic of insulin resistance and hyperglycemia seen with Type II diabetes. Traditionally, glucose cycling is determined by the difference between hepatic glucose output measured with separate [2-3H]glucose and [6-3H]glucose infusions. We demonstrate a novel method for determining hepatic glucose recycling from an intraperitoneal glucose tolerance test (IPGTT). A single tracer, [1, 2-13C(2)]glucose (a M2 glucose isotopomer), was administered at 1mg/g body weight to 4-month-old C57BL/6 mice. Hepatic glucose recycling was monitored by the appearance of a plasma M1 isotopomer of glucose, which is produced by the action of the pentose cycle on the M2 glucose isotopomer in the liver. The initial M2 enrichment was 56% and decreased to 13% at the end of 3 h, and the M1 enrichment peaked at 2 h. The ratio of plasma M1/M2 glucose increased linearly with time to approximately 25%, and the regression of the M1/M2 ratio against time gives a slope, termed the in vivo glucose-dependent futile recycling rate constant k(HR). k(HR) estimates glucose/glucose-6-phosphate futile cycling, along with glucose recycling through the pentose cycle. These observations demonstrate complex substrate cycling during an IPGTT using a single stable isotope tracer. Copyright 2003 Elsevier Science (USA)

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12689833     DOI: 10.1016/s0003-2697(02)00709-1

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  15 in total

1.  Early exercise regimen improves insulin sensitivity in the intrauterine growth-restricted adult female rat offspring.

Authors:  Meena Garg; Manikkavasagar Thamotharan; Shilpa A Oak; Gerald Pan; Duncan C Maclaren; Paul W N Lee; Sherin U Devaskar
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-11-11       Impact factor: 4.310

2.  Assessment of usnic acid toxicity in rat primary hepatocytes using ¹³C isotopomer distribution analysis of lactate, glutamate and glucose.

Authors:  Bakary J Sonko; Thomas C Schmitt; Lei Guo; Qiang Shi; Laszlo G Boros; Julian E A Leakey; Richard D Beger
Journal:  Food Chem Toxicol       Date:  2011-07-23       Impact factor: 6.023

3.  Advantages of dynamic "closed loop" stable isotope flux phenotyping over static "open loop" clamps in detecting silent genetic and dietary phenotypes.

Authors:  Bhavapriya Vaitheesvaran; Fu-Yu Chueh; Jun Xu; Chuck Trujillo; M F Saad; W N P Lee; Owen P McGuinness; Irwin J Kurland
Journal:  Metabolomics       Date:  2009-11-12       Impact factor: 4.290

4.  Role of the tumor suppressor IQGAP2 in metabolic homeostasis: Possible link between diabetes and cancer.

Authors:  B Vaitheesvaran; K Hartil; A Navare; P OBroin; A Golden; Wn Lee; I J Kurland; J E Bruce
Journal:  Metabolomics       Date:  2014-10-01       Impact factor: 4.290

5.  Embryo-transfer of the F2 postnatal calorie restricted female rat offspring into a control intra-uterine environment normalizes the metabolic phenotype.

Authors:  Meena Garg; Manikkavasagar Thamotharan; Yun Dai; Paul W N Lee; Sherin U Devaskar
Journal:  Metabolism       Date:  2012-09-27       Impact factor: 8.694

6.  MKR mice have increased dynamic glucose disposal despite metabolic inflexibility, and hepatic and peripheral insulin insensitivity.

Authors:  B Vaitheesvaran; D LeRoith; I J Kurland
Journal:  Diabetologia       Date:  2010-06-25       Impact factor: 10.122

7.  Characterizing phenotype with tracer based metabolomics.

Authors:  Wai Nang P Lee
Journal:  Metabolomics       Date:  2006-05-20       Impact factor: 4.290

8.  Early exposure of the pregestational intrauterine and postnatal growth-restricted female offspring to a peroxisome proliferator-activated receptor-{gamma} agonist.

Authors:  Meena Garg; Manikkavasagar Thamotharan; Gerald Pan; Paul W N Lee; Sherin U Devaskar
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-12-15       Impact factor: 4.310

9.  HKDC1 Is a Novel Hexokinase Involved in Whole-Body Glucose Use.

Authors:  Anton E Ludvik; Carolina M Pusec; Medha Priyadarshini; Anthony R Angueira; Cong Guo; Amy Lo; Korri S Hershenhouse; Guang-Yu Yang; Xianzhong Ding; Timothy E Reddy; William L Lowe; Brian T Layden
Journal:  Endocrinology       Date:  2016-07-26       Impact factor: 4.736

10.  Single valproic acid treatment inhibits glycogen and RNA ribose turnover while disrupting glucose-derived cholesterol synthesis in liver as revealed by the [U-C(6)]-d-glucose tracer in mice.

Authors:  Richard D Beger; Deborah K Hansen; Laura K Schnackenberg; Brandie M Cross; Javad J Fatollahi; F Tracy Lagunero; Zoltan Sarnyai; Laszlo G Boros
Journal:  Metabolomics       Date:  2009-03-31       Impact factor: 4.290

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.